Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities.
Publication
, Journal Article
Wang, EA; Zenilman, J; Brinkley-Rubinstein, L
Published in: JAMA
September 15, 2020
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
September 15, 2020
Volume
324
Issue
11
Start / End Page
1031 / 1032
Location
United States
Related Subject Headings
- Viral Vaccines
- Vaccination
- United States
- Therapeutic Human Experimentation
- SARS-CoV-2
- Prisoners
- Pneumonia, Viral
- Pandemics
- Humans
- General & Internal Medicine
Citation
APA
Chicago
ICMJE
MLA
NLM
Wang, E. A., Zenilman, J., & Brinkley-Rubinstein, L. (2020). Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities. JAMA, 324(11), 1031–1032. https://doi.org/10.1001/jama.2020.15589
Wang, Emily A., Jonathan Zenilman, and Lauren Brinkley-Rubinstein. “Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities.” JAMA 324, no. 11 (September 15, 2020): 1031–32. https://doi.org/10.1001/jama.2020.15589.
Wang EA, Zenilman J, Brinkley-Rubinstein L. Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities. JAMA. 2020 Sep 15;324(11):1031–2.
Wang, Emily A., et al. “Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities.” JAMA, vol. 324, no. 11, Sept. 2020, pp. 1031–32. Pubmed, doi:10.1001/jama.2020.15589.
Wang EA, Zenilman J, Brinkley-Rubinstein L. Ethical Considerations for COVID-19 Vaccine Trials in Correctional Facilities. JAMA. 2020 Sep 15;324(11):1031–1032.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
September 15, 2020
Volume
324
Issue
11
Start / End Page
1031 / 1032
Location
United States
Related Subject Headings
- Viral Vaccines
- Vaccination
- United States
- Therapeutic Human Experimentation
- SARS-CoV-2
- Prisoners
- Pneumonia, Viral
- Pandemics
- Humans
- General & Internal Medicine